tiprankstipranks
Innovent Biologics (HK:1801)
:1801

Compare Innovent Biologics (1801) vs. Competitors

26 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innovent Biologics
HK$86.30
HK$150.79B
144.97
78.31%
15 Buy
0 Hold
0 Sell
Strong Buy
3SBio
HK$23.88
HK$60.61B
6.36
79.16%
6 Buy
1 Hold
0 Sell
Strong Buy
Akeso, Inc.
HK$137.90
HK$126.93B
-84.52
58.60%
9 Buy
1 Hold
0 Sell
Strong Buy
RemeGen Co. Ltd. Class H
HK$108.40
HK$82.05B
51.47
258.94%
6 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.78
HK$43.32B
-22.62
69.83%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$82.35
HK$45.25B
34.57
171.33%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1801
Innovent Biologics
86.30
37.95
78.49%
HK:1530
3SBio
23.04
10.66
86.11%
HK:9926
Akeso, Inc.
137.90
50.20
57.24%
HK:9995
RemeGen Co. Ltd. Class H
108.40
75.00
224.55%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.78
10.64
70.28%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
82.35
50.50
158.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts